Literature DB >> 15566428

Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.

Shamindra Direkze1, Heike Laman.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the primary aetiological agent of at least three malignancies associated with HIV infection and immunosuppression: Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. KSHV encodes proteins that deregulate key checkpoints in the signalling pathways governing cell proliferation, which may ultimately contribute to the virus' oncogenic potential. To alter cellular signalling associated with proliferation, these viral proteins function like growth factor ligands/receptors, signal transduction proteins, transcription factors and cell cycle regulators. This review focuses on the mechanisms by which some KSHV-encoded proteins activate signalling pathways and cell proliferation and their role in the pathogenesis of KSHV-driven mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566428      PMCID: PMC2517533          DOI: 10.1111/j.0959-9673.2004.00407.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  119 in total

1.  A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sadler; L Wu; B Forghani; R Renne; W Zhong; B Herndier; D Ganem
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

Authors:  Y Aoki; E S Jaffe; Y Chang; K Jones; J Teruya-Feldstein; P S Moore; G Tosato
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

3.  Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.

Authors:  M Burger; J A Burger; R C Hoch; Z Oades; H Takamori; I U Schraufstatter
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

4.  Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Lagunoff; R Majeti; A Weiss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

5.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

Authors:  M E Ballestas; P A Chatis; K M Kaye
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

6.  Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines.

Authors:  H G Drexler; C Meyer; G Gaidano; A Carbone
Journal:  Leukemia       Date:  1999-04       Impact factor: 11.528

7.  Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis.

Authors:  J R Kirshner; K Staskus; A Haase; M Lagunoff; D Ganem
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end.

Authors:  L J Poole; J C Zong; D M Ciufo; D J Alcendor; J S Cannon; R Ambinder; J M Orenstein; M S Reitz; G S Hayward
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.

Authors:  X Wan; H Wang; J Nicholas
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

10.  Transcriptional activation by the human herpesvirus-8-encoded interferon regulatory factor.

Authors:  Florence Roan; James C Zimring; Stephen Goodbourn; Margaret K Offermann
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

View more
  13 in total

Review 1.  Virus manipulation of cell cycle.

Authors:  R Nascimento; H Costa; R M E Parkhouse
Journal:  Protoplasma       Date:  2011-10-11       Impact factor: 3.356

Review 2.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

3.  KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.

Authors:  Pawan Pyakurel; Fatemeh Pak; Amos R Mwakigonja; Ephata Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2007-02-02       Impact factor: 2.965

Review 4.  Chromatinization of the KSHV Genome During the KSHV Life Cycle.

Authors:  Timsy Uppal; Hem C Jha; Subhash C Verma; Erle S Robertson
Journal:  Cancers (Basel)       Date:  2015-01-14       Impact factor: 6.639

Review 5.  KSHV LANA--the master regulator of KSHV latency.

Authors:  Timsy Uppal; Sagarika Banerjee; Zhiguo Sun; Subhash C Verma; Erle S Robertson
Journal:  Viruses       Date:  2014-12-11       Impact factor: 5.048

Review 6.  KSHV Genome Replication and Maintenance.

Authors:  Pravinkumar Purushothaman; Prerna Dabral; Namrata Gupta; Roni Sarkar; Subhash C Verma
Journal:  Front Microbiol       Date:  2016-02-01       Impact factor: 5.640

Review 7.  KSHV and the Role of Notch Receptor Dysregulation in Disease Progression.

Authors:  Jennifer L DeCotiis; David M Lukac
Journal:  Pathogens       Date:  2017-08-04

Review 8.  Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA.

Authors:  Fang Wei; Jin Gan; Chong Wang; Caixia Zhu; Qiliang Cai
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

Review 9.  Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus.

Authors:  Enea Gino Di Domenico; Luigi Toma; Valentina Bordignon; Elisabetta Trento; Giovanna D'Agosto; Paola Cordiali-Fei; Fabrizio Ensoli
Journal:  Int J Mol Sci       Date:  2016-06-01       Impact factor: 5.923

10.  KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation.

Authors:  Roxanne C Strahan; Maria McDowell-Sargent; Timsy Uppal; Pravinkumar Purushothaman; Subhash C Verma
Journal:  PLoS Pathog       Date:  2017-07-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.